Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS"

268 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login